Not applicableUnknownNCT02992990What this trial is testingBladder Tumor Biopsy Study to Improve Preoperative Determination of Stage and GradeWho this might be right forBladder Cancer Baylor College of Medicine 30
Testing effectiveness (Phase 2)Study completedNCT02365766What this trial is testingNeoadjuvant Pembrolizumab in Combination With Gemcitabine Therapy in Cis-eligible/Ineligible UC SubjectsWho this might be right forUrothelial CarcinomaBladder Cancer Jason R. Brown 83
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06880757What this trial is testing177Lu-FAP-2286 Treatment in Urethelial Neoplasms: Utility and Safety as a Novel Treatment.Who this might be right forBladder (Urothelial, Transitional Cell) Cancer Metastatic or Unresectable Ankara University 10
Not applicableLooking for participantsNCT04970472What this trial is testingBio Clinical Collection of Urothelial CarcinomaWho this might be right forUrothelial CarcinomaBladder Cancer University Hospital, Toulouse 1,000
Testing effectiveness (Phase 2)Study completedNCT00023842What this trial is testingBCG With or Without Mitomycin in Treating Patients With Bladder CancerWho this might be right forBladder Cancer European Organisation for Research and Treatment of Cancer - EORTC 97
Early research (Phase 1)Study completedNCT02300610What this trial is testingEnzalutamide in Combination With Gemcitabine and Cisplatin in Bladder CancerWho this might be right forBladder CancerCarcinoma, Transitional CellRenal Pelvis Cancer+2 more H. Lee Moffitt Cancer Center and Research Institute 10
Testing effectiveness (Phase 2)Active Not RecruitingNCT02845323What this trial is testingNeoadjuvant Nivolumab With and Without Urelumab in Cisplatin-Ineligible or Chemotherapy-refusing Patients With Muscle-Invasive Urothelial Carcinoma of the BladderWho this might be right forUrothelial CarcinomaBladder Cancer Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 15
Testing effectiveness (Phase 2)WithdrawnNCT06050954What this trial is testingA Pilot Study of Circulating Tumor DNA Adaptive Risk Maintenance Approach for Bladder Cancer (CARMA)Who this might be right forMetastatic Urothelial Carcinoma Fox Chase Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00393809What this trial is testingSafety and Proof of Concept Study of Intravesical DTA-H19 in Patients With Superficial Bladder CancerWho this might be right forBladder Neoplasms Hebrew University of Jerusalem 18
Not applicableAvailableNCT06443944What this trial is testingAn Expanded Access Program of Cretostimogene Grenadenorepvec for Treatment of NMIBC for Patients Unresponsive to BCGWho this might be right forNon-Muscle Invasive Bladder CancerUrothelial CarcinomaUrologic Cancer+1 more CG Oncology, Inc.
Testing effectiveness (Phase 2)Study completedNCT03430895What this trial is testingEvaluating Immune Therapy, Durvalumab (MEDI4736) With Tremelimumab for Metastatic, Non-transitional Cell Carcinoma of the Urinary TractWho this might be right forNon-Transitional Cell Carcinoma of the Urothelial TractSmall Cell of the BladderAdenocarcinoma of the Bladder+2 more Memorial Sloan Kettering Cancer Center 15
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07414992What this trial is testingRadiation Therapy and Cemiplimab With or Without Fianlimab In People With Bladder CancerWho this might be right forBladder Urothelial Carcinoma Memorial Sloan Kettering Cancer Center 44
Testing effectiveness (Phase 2)Active Not RecruitingNCT04953104What this trial is testingARID1A and/or KDM6A Mutation and CXCL13 ExpressionWho this might be right forLocally Advanced Bladder Urothelial CarcinomaLocally Advanced Renal Pelvis Urothelial CarcinomaLocally Advanced Ureter Urothelial Carcinoma+29 more M.D. Anderson Cancer Center 6
Testing effectiveness (Phase 2)Study completedNCT00009867What this trial is testingArsenic Trioxide in Treating Patients With Urothelial CancerWho this might be right forRecurrent Transitional Cell Cancer of the Renal Pelvis and UreterRecurrent Urethral CancerTransitional Cell Carcinoma of the Bladder+1 more National Cancer Institute (NCI) 35
Early research (Phase 1)Looking for participantsNCT05614739What this trial is testingFORAGER-1: A Study of LOXO-435 (LY3866288) in Participants With Cancer With a Change in a Gene Called FGFR3Who this might be right forUrinary Bladder NeoplasmsNeoplasm MetastasisUreteral Neoplasms Eli Lilly and Company 535
Testing effectiveness (Phase 2)Looking for participantsNCT06364956What this trial is testingClinical Trail of Neoadjuvant of Tislelizumab Combined With Palbociclib in Patients With Platinum-refractory Bladder Urothelial CarcinomaWho this might be right forBladder Cancer Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 36
Testing effectiveness (Phase 2)Study completedNCT00002917What this trial is testingPaclitaxel in Treating Patients With Early-Stage Bladder CancerWho this might be right forBladder Cancer Mary Babb Randolph Cancer Center at West Virginia University Hospitals
Testing effectiveness (Phase 2)Study completedNCT01828736What this trial is testingEfficacy of Combination of Trastuzumab to Gemcitabine - Platinum Advanced or Metastatic Urothelial CarcinomaWho this might be right forRecurrent Bladder CancerStage IV Bladder CancerTransitional Cell Carcinoma of the Bladder Association Pour La Recherche des Thérapeutiques Innovantes en Cancérologie 61
Testing effectiveness (Phase 2)Active Not RecruitingNCT02447549What this trial is testingStudy of Tumour Focused Radiotherapy for Bladder CancerWho this might be right forBladder Cancer Institute of Cancer Research, United Kingdom 345
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07639983What this trial is testingMulti-Omics-Based Phase Ⅱ Trial of Trastuzumab Rezetecan Plus Camrelizumab for Perioperative Therapy in HER2-Positive Muscle-Invasive Urothelial CarcinomaWho this might be right forMuscle-Invasive Bladder Cancer (MIBC)Urinary Bladder Cancer Sheng Tai 44